Mohammad Hossein Rahimi-Rad1, Behzad Asgari2, Negar Hosseinzadeh3, Ali Eishi4. 1. College of Medicine, Urmia University of Medical Sciences, Urmia, Iran. 2. Urmia University of Medical Sciences, Urmia, Iran. 3. Research Center, Urmia University of Medical Sciences, Urmia, Iran. 4. Department of Hematology, Urmia University of Medical Sciences, Urmia, Iran.
Abstract
BACKGROUND: Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) is a common cause of hospitalization and mortality. Recent studies have shown the usefulness of eosinopenia in predicting the outcomes of patients admitted to the intensive care unit. This study examined the association of eosinopenia with the outcomes of patients with AECOPD. METHODS: This is a prospective study. Patients with AECOPD were divided into two cohorts: patients with eosinopenia and those without eosinopenia. Duration of hospitalization, need of mechanical ventilation, in-hospital mortality, rehospitalization, or death within 30 days after discharge were compared between the two cohorts. Eosinopenia was defined as eosinophil count of >40 cells/mm(3). RESULTS: Among 100 patients with AECOPD, 44 were eosinopenic and 56 were non-eosinopenic. Duration of hospitalization of patients with eosinopenia was 12.38 ± 9.85 days and that of patients without eosinopenia was 7.35 ± 5.68 days (p = 0.001). In all, 16 (36%) patients with eosinopenia and seven (12%) patients without eosinopenia needed mechanical ventilation (p = 0.005). In-hospital mortality rate among eosinopenic and noneosinopenic patients was 37.5% (12/44) and 7.6% (4/56), respectively (p = 0.006). Among 100 patients with AECOPD, 16 died in the hospital. Of these, 12 (27.27%) were eosinopenic and 4 (7.6%) were noneosinopenic (p = 0.006). The mean eosinophil count of patients who died in the hospital (n = 16) was 44.00 cells/ml whereas that of survivors (n = 84) was 107.41 cells/ml (p = 0.022). CONCLUSION: We conclude that a significant relationship exists between eosinopenia and outcomes of patients with AECOPD. Thus, eosinopenia can be a useful, easy-to-measure, and inexpensive biomarker for predicting the prognosis of patients with AECOPD.
BACKGROUND: Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) is a common cause of hospitalization and mortality. Recent studies have shown the usefulness of eosinopenia in predicting the outcomes of patients admitted to the intensive care unit. This study examined the association of eosinopenia with the outcomes of patients with AECOPD. METHODS: This is a prospective study. Patients with AECOPD were divided into two cohorts: patients with eosinopenia and those without eosinopenia. Duration of hospitalization, need of mechanical ventilation, in-hospital mortality, rehospitalization, or death within 30 days after discharge were compared between the two cohorts. Eosinopenia was defined as eosinophil count of >40 cells/mm(3). RESULTS: Among 100 patients with AECOPD, 44 were eosinopenic and 56 were non-eosinopenic. Duration of hospitalization of patients with eosinopenia was 12.38 ± 9.85 days and that of patients without eosinopenia was 7.35 ± 5.68 days (p = 0.001). In all, 16 (36%) patients with eosinopenia and seven (12%) patients without eosinopenia needed mechanical ventilation (p = 0.005). In-hospital mortality rate among eosinopenic and noneosinopenic patients was 37.5% (12/44) and 7.6% (4/56), respectively (p = 0.006). Among 100 patients with AECOPD, 16 died in the hospital. Of these, 12 (27.27%) were eosinopenic and 4 (7.6%) were noneosinopenic (p = 0.006). The mean eosinophil count of patients who died in the hospital (n = 16) was 44.00 cells/ml whereas that of survivors (n = 84) was 107.41 cells/ml (p = 0.022). CONCLUSION: We conclude that a significant relationship exists between eosinopenia and outcomes of patients with AECOPD. Thus, eosinopenia can be a useful, easy-to-measure, and inexpensive biomarker for predicting the prognosis of patients with AECOPD.
Entities:
Keywords:
COPD; duration of hospitalization; eosinopenia; mortality; outcome
Authors: Simon P Hogan; Helene F Rosenberg; Redwan Moqbel; Simon Phipps; Paul S Foster; Paige Lacy; A Barry Kay; Marc E Rothenberg Journal: Clin Exp Allergy Date: 2008-04-01 Impact factor: 5.018
Authors: Yoon Hee Kim; Hyun Bin Park; Min Jung Kim; Hwan Soo Kim; Hee Seon Lee; Yoon Ki Han; Kyung Won Kim; Myung Hyun Sohn; Kyu-Earn Kim Journal: J Korean Med Sci Date: 2013-01-08 Impact factor: 2.153
Authors: Daiana Stolz; Mirjam Christ-Crain; Nils G Morgenthaler; Jörg Leuppi; David Miedinger; Roland Bingisser; Christian Müller; Joachim Struck; Beat Müller; Michael Tamm Journal: Chest Date: 2007-04 Impact factor: 9.410
Authors: Jeffery Ho; Wajia He; Matthew T V Chan; Gary Tse; Tong Liu; Sunny H Wong; Czarina C H Leung; Wai T Wong; Sharon Tsang; Lin Zhang; Rose Y P Chan; Tony Gin; Joseph Leung; Benson W M Lau; William K K Wu; Shirley P C Ngai Journal: Sci Rep Date: 2017-10-18 Impact factor: 4.379
Authors: Maryse Bélanger; Simon Couillard; Josiane Courteau; Pierre Larivée; Thomas G Poder; Nathalie Carrier; Kim Girard; Felix-Antoine Vézina; Alain Vanasse Journal: Int J Chron Obstruct Pulmon Dis Date: 2018-10-01
Authors: Kjell E J Håkansson; Charlotte S Ulrik; Nina S Godtfredsen; Thomas Kallemose; Ove Andersen; Jesper Eugen-Olsen; Kristoffer Marsaa; Line J H Rasmussen Journal: Int J Chron Obstruct Pulmon Dis Date: 2020-04-05